Blood cancer diagnosis enters new era of precision testing

A new review examines how genetic and molecular testing is transforming how doctors diagnose chronic lymphocytic leukemia, moving beyond traditional methods. The shift matters to healthcare systems and drugmakers because better early detection could improve patient outcomes and reshape treatment strategies—key factors as the leukemia drug market expands globally.

Originaltitel: Precision diagnostics in chronic lymphocytic leukemia: Past, present and future